Dr. M-
At this point, it's an educated guess based on a pre-revenue company requiring at least $100MM to bring to market, including the $60M Tony mentioned to get through all the trials.
By eliminating all unknowns and speculation , the company is truly valued at $80M. That's simply the market capitalization. Regardless how strong any of us feels, and I do feel strong, the quick nickel is better than the slow dime. All the risk and financial capitalization will be on the buyer so they need enough meat on the bone to make it worthwhile. In retrospect, if CYDY was close they wouldn't sell. So it's a win/win based on market cap and what I would say is generous at 8x's value (stock price).
The science could be worth $10B per year but investors are saying "no" right now, hence a $.53 share price.
It's Neanderthal math and I admit it as I'm basing it off only a few variables but those data points are non-arguable at this point. I have close to 50k shares and got to an average price per share of $.55
Eight dollars would put a lot bread in the basket! As always, appreciate your valued input. Any time I get nervous, I read your thoughtful and well-reasoned, medically-backed posts and return to my bullish attitude!
Grip